Is Paracetamol + Pseudoephedrine + Triprolidine registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 3 valid registrations of Paracetamol + Pseudoephedrine + Triprolidine, including ACTODRYL Syrup (25,5,0.25 mg/ml,mg/ml,mg/ml, Syrup, SAR 12.00); RINOFED PLUS SYRUP (25,5,0.25 mg/ml,mg/ml,mg/ml, Syrup, SAR 10.80); RINOFED PLUS TAB (300,50,2.5 mg,mg,mg, Tablet, SAR 8.65).

Active substances

Paracetamol + Pseudoephedrine + Triprolidine

SFDA 3

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
ACTODRYL Syrup	25,5,0.25 mg/ml,mg/ml,mg/ml	Syrup · Oral use	1 Bottle	SAR 12.00	Generic · OTC	SAUDI PHARMACEUTICAL INDUSTRIES	Valid
RINOFED PLUS SYRUP	25,5,0.25 mg/ml,mg/ml,mg/ml	Syrup · Oral use	1 Bottle	SAR 10.80	Generic · OTC	Jazeera Pharmaceutical Industries (JPI)	Valid
RINOFED PLUS TAB	300,50,2.5 mg,mg,mg	Tablet · Oral use	30 Blister	SAR 8.65	Generic · OTC	Jazeera Pharmaceutical Industries (JPI)	Valid

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.